The leading U.S. liquefied natural gas exporter, Cheniere Energy, has declared a quarterly cash dividend of $0.555 per share, reinforcing its commitment to shareholder returns even as analysts adjust near-term price targets.
A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
President Trump's nomination of former Fed governor Kevin Warsh to lead the central bank has sparked immediate concerns on Wall Street about political influence over monetary policy, setting the stage for a contentious Senate confirmation battle.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
Shares in Lloyds Banking Group have surged over 18% in three months, reigniting investor interest. As the stock hovers near analyst targets, a key question emerges: does the UK banking giant still offer value, or has the market run ahead of itself?
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
A human rights group has cautioned New York state and city officials that investing public funds in Israeli government bonds may violate international law and fiduciary duties, exposing them to significant legal and financial risks.
A pivotal week in business saw Tesla's long-awaited robotaxis begin operations without safety drivers, signaling a new phase in autonomous mobility. Meanwhile, Greg Abel's early moves at Berkshire Hathaway hint at a potential strategic shift, and a push for tokenized, round-the-clock stock trading raises questions about the future of finance.
South Africa declares Israel's top diplomat persona non grata, citing 'gross abuse' of diplomatic privileges and social media attacks on its president. Israel responds in kind, expelling a South African envoy, as months of friction over the Gaza war reach a diplomatic boiling point.
Yemen's Houthi rebels have seized telecommunications equipment and vehicles from multiple UN offices in Sana'a, the United Nations reported Friday, marking a significant escalation in restrictions that threatens to cripple humanitarian operations in the war-torn country.
Canadian National Railway reported increased traffic, revenue, and operating income for the fourth quarter of 2025, citing productivity gains and a recovery from prior-year port disruptions. However, executives warn that ongoing U.S. trade policy uncertainty and tariffs continue to cloud the outlook for 2026.
The thrill of the hunt for luxury bargains is fading for American shoppers as Saks Global closes dozens of off-price physical stores. Experts explain the deep-seated psychology behind bargain hunting and what the retail landscape loses with these closures.
As sky-high valuations plague pure-play AI stocks, a global industrial landlord is emerging as a critical—and potentially undervalued—enabler of the artificial intelligence boom through its strategic pivot into data centers.
American Express reported a 10% revenue surge to $72 billion for 2025, driven by strong premium card demand and disciplined credit. Executives project 9-10% growth for 2026, betting on younger customers and strategic tech investments to sustain momentum.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
A U.S. license shift paves the way for Chevron to expand its unique position in Venezuela's oil sector, offering potential upside amid significant political and operational risks.
Fermi Inc. is confronting multiple class action lawsuits alleging it misled investors about tenant demand and funding risks for its flagship AI data center project, Project Matador. The legal challenges emerge as the company navigates a high-stakes, capital-intensive build-out in a competitive sector.
The United States has sanctioned Iran's Interior Minister and a prominent businessman, accusing them of human rights abuses and money laundering, as Washington intensifies pressure on Tehran amid ongoing regional tensions.
After years of de facto autonomy, Syria's Kurdish-led administration and military forces have agreed to a phased reintegration into the state, a move hailed by Washington as historic but met with caution on the ground.
